Baheal Pharma Group said on Thursday it had shipped the first China-manufactured ZAP-X radiosurgery robot, marking the first global deliveries of the brain tumor treatment system from a production base in northern China.
The shipment from a manufacturing facility in the Beijing Daxing International Airport Economic Zone marks a milestone in the company's efforts to expand into the high-end radiation therapy equipment market and establish China as a global production hub for the device.
ZAP-X, developed by US-based ZAP Surgical Systems, is a robotic radiosurgery platform designed to treat intracranial and head-and-neck tumors and lesions. The system was created by neurosurgeon John Adler, the inventor of the CyberKnife radiosurgery system.
Baheal invested in ZAP Surgical in 2024 and entered a broad partnership covering manufacturing, commercialization and clinical deployment of the technology. Under the arrangement, a Sino-US joint venture operates the Chinese production facility, which serves as a global manufacturing center for the system.
The company said devices produced at the plant will be shipped to markets including the United States, the Netherlands and Japan following the initial delivery.
